People · Operator
Named in public records as an officer, director or promoter · active 2009–2015 · Biotechnology, Other Health Care, Business Services
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Anulex Technologies Inc | — | Biotechnology | Series B | $32.3M | $724.8M | 2009 |
| Pursuit Vascular, Inc. | — | Other Health Care | Series A | $12.3M | $42.1M | 2014 |
| Amyx Inc | — | Business Services | Pre-Seed | $922K | $18.3M | 2009 |
Dale Spencer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dale Spencer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| BUZZ BENSON | 1 | 8 |
| Kevin Roche | 1 | 6 |
| Mike Sherman | 1 | 6 |
| Mark Hughes | 1 | 5 |
| Timothy Miller | 1 | 4 |
| A. Jay Graf | 1 | 3 |
| Dave Stassen | 1 | 3 |
| Doug Roeder | 1 | 2 |
| Jay Graf | 1 | 2 |
| Matt Meyer | 1 | 2 |
| Robert Ziebol | 1 | 2 |
| Satya Akula | 1 | 2 |
| James Porter | 1 | 2 |
| Jack Helms | 1 | 2 |
| Steven Frazier | 1 | 2 |
| Roy Martin, Jr. | 1 | 1 |
| THERESA FAYE GRANGER | 1 | 1 |
| STEVEN FAYE FRAZIER | 1 | 1 |
| Robert Weinmann, M.D. | 1 | 1 |
| Doug Killion | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.